14 completed, 9 terminated, 1 unknown, 1 withdrawn. 13 Phase 4, 10 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 7, Terminated 5, Withdrawn 1 |
| Phase 3 | 10 | Completed 6, Terminated 4 |
| Phase 2 | 1 | Unknown 1 |
Follow telithromycin: new trials by email Literature Review of telithromycin trials Research Report on telithromycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TELI TON - Telithromycin in Tonsillitis Telithromycin (HMR3647), Penicillin - Tonsillitis, Pharyngitis | Phase 3 | Terminated | Sanofi | 314 | 2006-03-01 | 2009-04-03 |
| TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults Telithromycin, Penicillin - Tonsillitis, Pharyngitis | Phase 3 | Terminated | Sanofi | 233 | 2006-02-01 | 2009-04-03 |
| Intrapulmonary Pharmacokinetics of Antibiotics Telithromycin, azithromycin, bronchoalveolar lavage - Healthy | Phase 4 | Terminated | University of Illinois at Chicago | 35 | 2006-01-01 | 2009-02-13 |
| Telithromycin in Acute Exacerbation of Chronic Bronchitis Telithromycin - Bronchitis, Chronic | Phase 4 | Terminated | Sanofi | 54 | 2006-01-01 | 2009-12-09 |
| TELI COM - Telithromycin in Children With Otitis Media Telithromycin, Azithromycin - Otitis Media, Suppurative, Otitis Media, Purulent | Phase 3 | Terminated | Sanofi | 1500 | 2006-01-01 | 2009-04-03 |
| Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis Azithromycin, Telithromycin - Maxillary Sinusitis | Phase 4 | Terminated | CPL Associates | 192 | 2005-12-01 | 2007-10-31 |
| Comparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia EDP-420 / Duration of Treatment - 3 days, Telithromycin / Duration of Treatment - 7 days - Community Acquired Pneumonia | Phase 2 | Unknown | Enanta Pharmaceuticals, Inc | 250 | 2005-12-01 | 2006-09-19 |
| Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 Days telithromycin, azithromycin - Pneumonia | Phase 4 | Terminated | Sanofi | 110 | 2005-11-01 | 2011-01-11 |
| Outpatient Registry Trial of Respiratory Tract Infections in Adults azithromycin, telithromycin, Clarythromycin - Pneumonia, Bacterial, Bronchitis, Chronic | Phase 4 | Withdrawn | CPL Associates | 2005-10-01 | 2015-07-28 | |
| Controlled Trial: 5-day Course of Telithromycin Versus Doxycycline for the Treatment of Mild to Moderate Scrub Typhus Telithromycin, Doxycycline - Scrub Typhus | Phase 3 | Completed | Dong-Min Kim | 92 | 2005-09-01 | 2019-02-08 |
| Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear Infections telithromycin (HMR3647) - Otitis Media | Phase 3 | Terminated | Sanofi | 639 | 2005-06-01 | 2009-04-03 |
| Telithromycin in Respiratory Tract Infections telithromycin - Respiratory Tract Infections | Phase 4 | Completed | Sanofi | 2005-02-01 | 2009-09-25 | |
| CHOOSE : Telithromycin, Acute Bacterial Sinusitis Telithromycin - Sinusitis | Phase 4 | Completed | Sanofi | 298 | 2004-11-01 | 2009-09-25 |
| Comparative Effects of Azithromycin, Telithromycin and Levofloxacin on Drug Metabolizing Enzymes Cooperstown 5+1 alone, Azithromycin plus Cooperstown 5+1, Telithromycin plus Cooperstown 5+1 - Healthy | Phase 4 | Completed | Bassett Healthcare | 16 | 2004-11-01 | 2005-09-14 |
| KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections Telithromycin, Azithromycin - Respiratory Tract Infections, Chronic Bronchitis | Phase 4 | Terminated | Sanofi | 2051 | 2004-10-01 | 2009-08-27 |
| Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With Infections telithromycin (HMR3647) - Infections, Child | Phase 3 | Completed | Sanofi | 111 | 2004-08-01 | 2009-04-03 |
| Ketek in CAP / AECB in Ambulatory Adult Patients Telithromycin - Community Acquired Pneumonia (CAP), Acute Exacerbation of Chronic Bronchitis (AECB) | Phase 4 | Completed | Sanofi | 174 | 2004-05-01 | 2007-11-14 |
| Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia Telithromycin (HMR3647) - Pneumonia | Phase 3 | Completed | Sanofi | 56 | 2004-03-01 | 2009-10-02 |
| Japanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis Media Telithromycin (HMR3647) - Otitis Media | Phase 3 | Completed | Sanofi | 56 | 2004-02-01 | 2009-10-02 |
| PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis telithromycin - Chronic Bronchitis | Phase 4 | Completed | Sanofi | 5660 | 2004-01-01 | 2011-06-08 |
Showing 20 of 25. Sign in to see all of them.
Bronchitis, Chronic (5) · Pneumonia (5) · Community-Acquired Pneumonia (3) · Otitis Media (3) · Respiratory Tract Infections (3) · Sinusitis (3) · Maxillary Sinusitis (2) · Pharyngitis (2) · Tonsillitis (2) · Asthma (1) · Bronchitis (1) · Chemical and Drug Induced Liver Injury (1) · Focal Facial Dermal Dysplasias (1) · Infections (1) · Liver Diseases (1)
Sanofi (18) · CPL Associates (2) · Bassett Healthcare (1) · Bayer (1) · Dong-Min Kim (1) · Enanta Pharmaceuticals, Inc (1) · University of Illinois at Chicago (1)
United States (13) · Argentina (3) · Chile (3) · Costa Rica (3) · Japan (3) · Canada (2) · France (2) · Panama (2) · Turkey (Türkiye) (2) · Belgium (1) · Brazil (1) · Colombia (1) · Czechia (1) · Dominican Republic (1) · Guatemala (1)
Gilles Perdriset, MD (2) · Jerome J Schentag, Pharm.D. (2) · Joseph Paladino, Pharm.D. (2) · Dong-Min Kim (1) · Edibe Taylan (1) · Gilles Perdriset (1) · Joseph S Bertino, Pharm.D. (1) · Keith A. Rodvold, Pharm.D. (1) · Larry H. Danziger, Pharm.D. (1) · Margaret Mississian (1) · Mark H. Gotfried, M.D. (1)